Zarina Begum

Immunology and Microbiology · Life Sciences

5h-index102citations11works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune cells in cancer(5), Immunotherapy and Immune Responses(4), Neuroinflammation and Neurodegeneration Mechanisms(4), RNA Interference and Gene Delivery(3), Chemokine receptors and signaling(3)

Publications11 total

Mode of pP38 and Nf-kand946 Signalling Pathway on Induction of Apoptosis in Response to Flavonoids of Aloe Vera in Glioblastoma
International Journal of Scientific Research in Biological Sciences·2019Open Access
Erythropoietin (Epo), Erythropoietin Receptor (EpoR) and Red Cell Development- Deciphering Molecular Connections
2012Open Access
Immunological profile of arsenic toxicity: a hint towards arsenic-induced carcinogenesis.
PubMed·2010· 20 cited
Differential regulation of the protein tyrosine kinase activity followingiInterleukin-2 (IL-2), Interferron gamma (IFN?) and SRBC administration in brain tumor induced conditions: SRBC acting as a dual potentiator in regulating the cytokine profile
Cancer Biology & Therapy·2004· 8 citedOpen Access
An Immunological approach towards the functional activation of microglia in brain with and without tumor: Hints for therapeutic modulation
Shodhganga·2004
Brain tumor inhibition in experimental model by restorative immunotherapy with a corpuscular antigen.
PubMed·2003· 3 cited
Evaluation of Anti-tumor property of Specific and Non-specific BRMs in Experimental Glioma by Assessing the Microglial Cell Functional and Phenotypic Modulations
Cancer Biology & Therapy·2003· 5 cited
Documentation of immune profile of microglia through cell surface marker study in glioma model primed by a novel cell surface glycopeptide T11TS/SLFA-3
Glycoconjugate Journal·2003· 19 cited
Sheep form of leucocyte function antigen-3 (T11TS) exerts immunostimulatory and anti-tumor activity against experimental brain tumor. A new approach to biological response modifier therapy.
PubMed·2002· 21 cited
Preclinical Changes in Immunoreactivity and Cellular Architecture during the Progressive Development of Intracranial Neoplasms and an Immunotherapeutic Schedule with a Novel Biological Response Modifier, the T11TS / S-LFA3.
PubMed·2002· 26 cited
Stress induced shedding of a tumor antigen by a rat histiocytic cell line AK-5: a possible mechanism of immune evasion.
PubMed·1998

Frequent Co-authors

Swapna Chaudhuri(7), Sneha Dutta(3), Sujan Kumar Sarkar(3), Anirban Ghosh(3), Samares Chaudhuri(2), Susobhan Sarkar(2), Joydeep Mukherjee(2), Joydeep Mukherjee(1), Sagar Acharya(1), Suhnrita Chaudhuri(1), Sirshendu Chatterjee(1), Pankaj Kumar(1), Shyamal Dasgupta(1), S.J.S. Flora(1), Malabika Mazumdar(1), Piyali Sarkar(1), M. Bhattacharjee(1), Srimonti Sarkar(1), Shanta Dutta(1), R.U. Roy(1)